ATC CODE
- L04AA31
INDICATION
- Relapsing remitting multiple sclerosis.
NEMLC RECOMMENDATION
- Approved
- Provided offered price is comparable or lower than beta interferon
REVIEW INDICATORS
- New evidence of clear benefit of efficacy of newer classes
- Price changes
DATE RATIFIED
- 19 March 2020